SeekingAlpha · Aug 18, 2026
Stryker Corporation: Hold For Quality, Wait For The Dip
Stryker is a MedTech compounder with 11% organic revenue growth and expanding margins. Click here to read why SYK stock is a Hold.
GN
OTC · GNGBY
Getinge AB (publ)
Healthcare · Medical - Devices
$23.93
Down-$0.32 (-1.30%)
Updated Sep 19, 2026, 5:44 AM
SID Score
4.9/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 6.15B
- P/E ratio
- 27.86
- Dividend yield
- 2.00%
- 52-week range
- — – —
- Volume
- 300
- Avg. volume
- 1.63K
Price performance
GNGBY price history
1M range · 0 trading sessions · Daily adjusted prices
GNGBY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest GNGBY news
The latest Smart Investors Daily articles mentioning GNGBY.
Stock researchCompany · Overview
GNGBY research
Overview
Company profile and research snapshot.
Company profile
GETINGE AB UNSP/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 13, 2026 | PARETO SECURITIES AS | Buy | — |
| Jul 7, 2026 | DNB CARNEGIE | Buy | — |
| Jul 2, 2026 | HANDELSBANKEN CAPITAL MARKETS | Hold | — |
| Jul 2, 2026 | EQUITA SIM | Hold | — |
| Feb 6, 2026 | EQUITA SIM | Hold | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Jul 17, 2026
Getinge AB (publ) (GNGBY) Q2 2026 Earnings Call Transcript
Getinge AB (publ) (GNGBY) Q2 2026 Earnings Call July 17, 2026 4:00 AM EDTCompany ParticipantsMattias Perjos - CEO, President & DirectorAgneta Palmer -...
SeekingAlpha · Jul 17, 2026
Getinge AB (publ) 2026 Q2 - Results - Earnings Call Presentation
2026-07-17. The following slide deck was published by Getinge AB (publ) in conjunction with their 2026 Q2 earnings call.
Yahoo · Apr 28, 2026
Getinge Board Refresh Links Governance Shifts To Dividend And Growth Choices
Getinge (OM:GETI B) plans significant board changes at its 2026 AGM. Shareholders are set to vote on the election of Camilla Sylvest to the board. New employee representatives are also expected to join the board, reshaping its composition. Getinge, a global provider of medical technology and life science solutions, is closely watched by investors who follow corporate governance and board expertise. Changes to the board at the 2026 AGM put the focus on how the company aligns oversight with...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
